Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

PROSTASCINT

CAPROMAB PENDETIDE

Standard Dose
05.MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview PROSTASCINT is listed in Drugs@FDA under application 103608 (BLA).

Marketing status: Prescription Active ingredient CAPROMAB PENDETIDE Form and strength VIAL; INTRAVENOUS - 05.MG/ML Sponsor CYTOGEN Submission history Latest submission status date: 2012-06-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROSTASCINT is listed in Drugs@FDA under application 103608 (BLA). Marketing status: Prescription Active ingredient CAPROMAB PENDETIDE Form and strength VIAL; INTRAVENOUS - 05.MG/ML Sponsor CYTOGEN Submission history Latest submission status date: 2012-06-26 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.